Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 7
1994 2
1995 6
1996 10
1997 29
1998 50
1999 94
2000 121
2001 84
2002 108
2003 98
2004 74
2005 89
2006 83
2007 50
2008 58
2009 40
2010 35
2011 27
2012 33
2013 29
2014 21
2015 28
2016 17
2017 14
2018 13
2019 8
2020 6
2021 3
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

1,166 results
Results by year
Filters applied: . Clear all
Page 1
The association of Chlamydia pneumoniae infection with atherosclerosis: Review and update of in vitro and animal studies.
Khoshbayan A, Taheri F, Moghadam MT, Chegini Z, Shariati A. Khoshbayan A, et al. Microb Pathog. 2021 May;154:104803. doi: 10.1016/j.micpath.2021.104803. Epub 2021 Feb 17. Microb Pathog. 2021. PMID: 33609645 Review.
Previous studies have tended to relate Chlamydia pneumoniae (Cpn) infection to atherosclerosis. However, while serological studies have mostly reinforced this hypothesis, inconsistent and even contradictory findings have been reported in various researches. . …
Previous studies have tended to relate Chlamydia pneumoniae (Cpn) infection to atherosclerosis. However, while serologi …
Chlamydia pneumoniae and atherosclerosis.
Belland RJ, Ouellette SP, Gieffers J, Byrne GI. Belland RJ, et al. Cell Microbiol. 2004 Feb;6(2):117-27. doi: 10.1046/j.1462-5822.2003.00352.x. Cell Microbiol. 2004. PMID: 14706098 Review.
Exposure to Chlamydia pneumoniae is extremely common, and respiratory infections occur repeatedly among most people. Strong associations exist between C. pneumoniae infection and atherosclerosis as demonstrated by: (i) sero-epidemiological studies show …
Exposure to Chlamydia pneumoniae is extremely common, and respiratory infections occur repeatedly among most people. Strong as …
Chlamydia pneumoniae and atherosclerosis.
Campbell LA, Kuo CC. Campbell LA, et al. Semin Respir Infect. 2003 Mar;18(1):48-54. doi: 10.1053/srin.2003.50006. Semin Respir Infect. 2003. PMID: 12652454 Review.
Chlamydia pneumoniae is a human respiratory pathogen that causes acute respiratory disease. ...The most critical question to be answered by researchers in the field is whether C. pneumoniae plays a role in atherogenesis. This review summarizes in vitro studie
Chlamydia pneumoniae is a human respiratory pathogen that causes acute respiratory disease. ...The most critical question to b
Chlamydia pneumoniae and atherosclerosis.
Wong YK, Gallagher PJ, Ward ME. Wong YK, et al. Heart. 1999 Mar;81(3):232-8. doi: 10.1136/hrt.81.3.232. Heart. 1999. PMID: 10026342 Free PMC article. Review.
OBJECTIVE: To review the literature for evidence that chronic infection with Chlamydia pneumoniae is associated with atherosclerosis and acute coronary syndromes. ...Rabbit models and preliminary antibiotic trials suggest that the organism might exacerbate …
OBJECTIVE: To review the literature for evidence that chronic infection with Chlamydia pneumoniae is associated with athero
Chlamydia pneumoniae and atherosclerosis.
Ouchi K. Ouchi K. Jpn J Infect Dis. 1999 Dec;52(6):223-7. Jpn J Infect Dis. 1999. PMID: 10738358 Review.
Chlamydia pneumoniae is the third species of the genus Chlamydia and has been known to cause respiratory tract infections. Since the association between the seropositivity of C. pneumoniae and ischemic heart diseases was reported in 1988, the associati
Chlamydia pneumoniae is the third species of the genus Chlamydia and has been known to cause respiratory tract infectio
Chlamydia pneumoniae in atherosclerosis.
Saikku P. Saikku P. J Intern Med. 2000 Mar;247(3):391-6. doi: 10.1046/j.1365-2796.2000.00659.x. J Intern Med. 2000. PMID: 10762457 Free article. Review.
Chlamydia pneumoniae is currently the infectious agent most often associated with the inflammation found in atherosclerosis. ...Recently, several studies have suggested mechanisms by which C. pneumoniae infection could participate in the development of
Chlamydia pneumoniae is currently the infectious agent most often associated with the inflammation found in atherosclerosis
Chlamydia pneumoniae and atherosclerosis.
Hoymans VY, Bosmans JM, Ieven M, Vrints CJ. Hoymans VY, et al. Acta Chir Belg. 2002 Oct;102(5):317-22. doi: 10.1080/00015458.2002.11679323. Acta Chir Belg. 2002. PMID: 12471763 Review.
Chlamydia pneumoniae, a human respiratory pathogen, has been linked to atherosclerotic disease based on sero-epidemiologic studies, direct detection of the organism in atherosclerotic lesions, animal experiments and tissue culture. In this review paper we propose to
Chlamydia pneumoniae, a human respiratory pathogen, has been linked to atherosclerotic disease based on sero-epidemiologic stu
Chlamydia pneumoniae and atherosclerosis -- what we know and what we don't.
Ngeh J, Anand V, Gupta S. Ngeh J, et al. Clin Microbiol Infect. 2002 Jan;8(1):2-13. doi: 10.1046/j.1469-0691.2002.00382.x. Clin Microbiol Infect. 2002. PMID: 11906495 Free article. Review.
Although cytomegalovirus, Helicobacter pylori and Chlamydia pneumoniae are the three micro-organisms most extensively studied, this review will focus on C. pneumoniae. ...Pathological studies have demonstrated the preferential existence of C. pneumoniae
Although cytomegalovirus, Helicobacter pylori and Chlamydia pneumoniae are the three micro-organisms most extensively studied, …
Chlamydia pneumoniae and atherosclerosis: current state and future prospectives.
Sessa R, Nicoletti M, Di Pietro M, Schiavoni G, Santino I, Zagaglia C, Del Piano M, Cipriani P. Sessa R, et al. Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):9-14. doi: 10.1177/039463200902200102. Int J Immunopathol Pharmacol. 2009. PMID: 19309547 Free article. Review.
Chlamydia pneumoniae, an intracellular bacterial pathogen, is known as a leading cause of human respiratory tract infections worldwide. ...This review will provide an update on the role of C. pneumoniae in atherosclerosis focusing on the recent insight
Chlamydia pneumoniae, an intracellular bacterial pathogen, is known as a leading cause of human respiratory tract infections w
Chlamydia pneumoniae-Mediated Inflammation in Atherosclerosis: A Meta-Analysis.
Filardo S, Di Pietro M, Farcomeni A, Schiavoni G, Sessa R. Filardo S, et al. Mediators Inflamm. 2015;2015:378658. doi: 10.1155/2015/378658. Epub 2015 Aug 9. Mediators Inflamm. 2015. PMID: 26346892 Free PMC article. Review.
Therefore, we performed a meta-analysis to clarify whether C. pneumoniae may contribute to the pathogenesis of atherosclerosis by enhancing inflammation. 12 case-control, 6 cross-sectional, and 7 prospective studies with a total of 10,176 patients have been included …
Therefore, we performed a meta-analysis to clarify whether C. pneumoniae may contribute to the pathogenesis of atherosclerosis
1,166 results